# Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

> **NCT01124539** · PHASE2 · UNKNOWN · sponsor: **Arno Therapeutics** · enrollment: 58 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- GBM
- Gliosarcoma

## Interventions

- **DRUG:** AR-67 (7-t-butyldimethylsiltyl-10-hydroxy-camptothecin)

## Key facts

- **NCT ID:** NCT01124539
- **Lead sponsor:** Arno Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2014-09
- **Final completion:** 2015-02
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2014-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124539, "Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01124539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*